Harbor Advisors’s Teladoc Health TDOC Stock Holding History

Harbor Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,000	Closed	-$310K	–	153
2020 Q1	$310K	Buy	+2,000	New	+$233K	0.09%	86
2019 Q4	–	Sell	-5,000	Closed	-$339K	–	171
2019 Q3	$339K	Hold	5,000	–	–	0.1%	119
2019 Q2	$332K	Hold	5,000	–	–	0.1%	119
2019 Q1	$278K	Hold	5,000	–	–	0.09%	132
2018 Q4	$248K	Buy	+5,000	New	+$306K	0.1%	132

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harbor Advisors's TDOC Position: Q2 2020 in Review

Harbor Advisors sold out of Teladoc Health (TDOC) in Q2 2020, closing a stake of 2,000 shares — an estimated $310K sold.

Harbor Advisors first reported a position in TDOC in Q4 2018 and held it in 5 quarters. The position peaked at $339K in Q3 2019. 670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

Harbor Advisors reported no remaining Teladoc Health position as of Q2 2020 after selling out during the quarter.
Harbor Advisors sold 2,000 Teladoc Health shares in Q2 2020, an estimated $310K.
Harbor Advisors first reported a position in Teladoc Health in Q4 2018 and held it in 5 quarters.
Harbor Advisors's Teladoc Health position peaked at $339K in Q3 2019.
670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Harbor Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.